Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Announcement
Sort By
Newest First
1 / 6
1 / 6
Announcement
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference
Theravance Biopharma
PR-12-24-NI-137
Dec 17, 2024
Announcement
Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications
Karyopharm Therapeutics Inc.
PR-12-24-NI-135
Dec 12, 2024
Large Molecule
Bio-Techne and ALZpath Announce Strategic Partnership to Advance Neurdegenerative Disease Research
Bio-Techne Corporation
PR-11-24-NI-109
Nov 20, 2024
Announcement
Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland
Abbott
PR-11-24-NI-108
Nov 19, 2024
Clinical Trials
Concerto Biosciences Announces First Participant Dosed with Live Biotherapeutic ENS-002 in Phase 1 Trial for Atopic Dermatitis
Concerto Biosciences
PR-11-24-NI-112
Nov 19, 2024
Announcement
Genomadix Inc. Enters into Collaboration with Mayo Clinic on Precision Medicine for Telestroke
Genomadix
PR-11-24-NI-106
Nov 15, 2024
Announcement
Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio
Flagship Pioneering
PR-10-24-NI-97
Nov 13, 2024
Announcement
Bio-Techne To Present At Investor Conferences
Bio-Techne Corporation
PR-10-24-NI-87
Nov 08, 2024
Announcement
Celebrating More than a Decade of Excellence at the World ADC Awards – Winners Announcement
World ADC
PR-10-24-NI-77
Nov 08, 2024
Announcement
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer
I-Mab
PR-10-24-NI-80
Nov 07, 2024
Clinical Trials
Precision Biologics to Announce Development of New Monoclonal Antibody (mAb) PB-223 at SITC, Houston, TX, November 7-8, 2024
Precision Biologics
PR-10-24-NI-78
Nov 07, 2024
Announcement
Pharma Tech Industries Names Darrin T. Schellin New CEO
Pharma Tech Industries
PR-10-24-NI-69
Oct 30, 2024
Announcement
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
SK bioscience
PR-10-24-NI-59
Oct 23, 2024
Announcement
Orasis Pharmaceuticals Announces Licensing Agreement with Optus Pharmaceuticals for Commercialization of Qlosi™ 0.4% in Korea
Orasis Pharmaceuticals
PR-10-24-NI-49
Oct 17, 2024
Clinical Trials
Triumvira Immunologics Announces Publication Demonstrating the Safety and Efficacy of TAC T Cells Targeting Claudin 18.2
Triumvira Immunologics Inc.
PR-10-24-NI-47
Oct 16, 2024
Announcement
Genezen Appoints Mike Wourms as Chief Operations Officer
Genezen
PR-10-24-NI-36
Oct 08, 2024
Anniversary
Alconox Inc. Announced Its 75th Anniversary as an Internationally Distributed Manufacturer of Critical Cleaning Detergents
Alconox Inc.
PR-M06-21-017
Jun 09, 2021
Clinical Trial Services
CVS Health Introduces Clinical Trial Services
CVS Health
PR-M05-21-016-981
May 21, 2021
CPhI China
Opportunities Abound in China’s Pharmaceutical Market
CPhI & P-MEC China
PAP-Q1-20-CL-024
Mar 19, 2020
Coronavirus
INTERPHEX Postponed Due to COVID-19
INTERPHEX
PR-M03-20-NI-012
Mar 10, 2020
